HomeInsightsStock Comparison

Glenmark Pharmaceuticals Ltd vs Torrent Pharmaceuticals Ltd Stock Comparison

Glenmark Pharmaceuticals Ltd vs Torrent Pharmaceuticals Ltd Stock Comparison

Last Updated on: May 12, 2025

Key Highlights

  • The Latest Trading Price of Glenmark Pharmaceuticals Ltd is ₹ 1385 as of 12 May 10:30.
  • The P/E Ratio of Glenmark Pharmaceuticals Ltd changed from 7.5 on March 2020 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Torrent Pharmaceuticals Ltd changed from 32.6 on March 2020 to 53.2 on March 2024 . This represents a CAGR of 10.29% over 5 years.
  • The Market Cap of Glenmark Pharmaceuticals Ltd changed from ₹ 5814 crore on March 2020 to ₹ 27019 crore on March 2024 . This represents a CAGR of 35.97% over 5 yearsThe Market Cap of Torrent Pharmaceuticals Ltd changed from ₹ 33361 crore on March 2020 to ₹ 88030 crore on March 2024 . This represents a CAGR of 21.42% over 5 years.
  • The revenue of Glenmark Pharmaceuticals Ltd for the Dec '24 is ₹ 3418 crore as compare to the Sep '24 revenue of ₹ 3473 crore. This represent the decline of -1.57% The revenue of Torrent Pharmaceuticals Ltd for the Dec '24 is ₹ 2842 crore as compare to the Sep '24 revenue of ₹ 2873 crore. This represent the decline of -1.08%.
  • The ebitda of Glenmark Pharmaceuticals Ltd for the Dec '24 is ₹ 631.36 crore as compare to the Sep '24 ebitda of ₹ 641.33 crore. This represent the decline of -1.55% The ebitda of Torrent Pharmaceuticals Ltd for the Dec '24 is ₹ 947 crore as compare to the Sep '24 ebitda of ₹ 923 crore. This represent the growth of 2.6%.
  • The net profit of Glenmark Pharmaceuticals Ltd changed from ₹ 173.13 crore to ₹ 348.03 crore over 7 quarters. This represents a CAGR of 49.03% The net profit of Torrent Pharmaceuticals Ltd changed from ₹ 378 crore to ₹ 503 crore over 7 quarters. This represents a CAGR of 17.73% .
  • The Dividend Payout of Glenmark Pharmaceuticals Ltd changed from 5.21 % on March 2020 to 1.37 % on March 2024 . This represents a CAGR of -23.44% over 5 yearsThe Dividend Payout of Torrent Pharmaceuticals Ltd changed from 57.71 % on March 2020 to 69.83 % on March 2024 . This represents a CAGR of 3.89% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Glenmark Pharmaceuticals Ltd

  • Glenmark Pharmaceuticals Ltd was incorporated in November 18th, 1977.
  • The Company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity).
  • It is engaged in the business of development, manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets. The company has several molecules in various stages of pre-clinical and clinical development primarily focused in the areas of Oncology, Respiratory and Dermatology.
  • Its branded generics business has a significant presence in markets across emerging economies including India.
  • The company has 14 manufacturing facilities across US, India, Argentina, Czech Republic and Switzerland.

About Torrent Pharmaceuticals Ltd

  • Torrent Pharmaceuticals Limited is a leading player in the Indian pharmaceutical sector, concentrating on the chronic and sub-chronic therapeutic segments.
  • The Company has established itself as a leader in developing niche pharmaceutical solutions through its patient-centric innovation.
  • The Company is a dominant player in the therapeutic areas of Cardiovascular (CV), Central Nervous System (CNS), Vitamins and Nutrients (VMN), Gastro-Intestinal (GI) and Anti-Diabetes (AD) therapies in India.
  • It has a strong international presence across more than 40 countries with operations in regulated and emerging markets, such as the US, Europe, Germany, Brazil and Rest of the World. The Company operates through its wholly-owned subsidiaries spread across 12 countries with major setups in the US, Germany and Brazil.

Glenmark Pharmaceuticals Ltd News Hub

News

Ichnos Glenmark Innovation receives USFDA fast track designation for ISB 2001

IGI (Ichnos Glenmark Innovation), a global, fully integrated clinical-stage biotechnology ...

Read more

05 May 2025 19:16

News

Glenmark Pharma's US arm set to launch generic Adderall tablets

The company will launch Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroampheta...

Read more

17 Apr 2025 08:04

News

Glenmark Pharmaceuticals allots 12,653 equity shares under ESOP

Glenmark Pharmaceuticals has allotted 12,653 equity shares under ESOP. Consequently, the p...

Read more

17 Apr 2025 20:08

News

Glenmark USA to launch Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets

Glenmark Pharmaceuticals Inc., USA (Glenmark) announced the upcoming launch of Dextroamphe...

Read more

16 Apr 2025 19:53

News

Glenmark Pharmaceuticals Ltd slips for fifth straight session

Glenmark Pharmaceuticals Ltd dropped for a fifth straight session today. The stock is quot...

Read more

11 Apr 2025 13:35

News

Glenmark Pharmaceuticals announces change in senior management

Glenmark Pharmaceuticals has appointed Anurag Mantri as President (Senior Management Perso...

Read more

07 Apr 2025 09:00

Torrent Pharmaceuticals Ltd News Hub

News

Torrent Pharmaceuticals announces resignation of ED (Strategic Planning)

Torrent Pharmaceuticals announced that Pranav Mehta, Executive Director (Strategic Plannin...

Read more

27 Feb 2025 18:47

News

Torrent Pharmaceuticals Ltd rises for third consecutive session

Torrent Pharmaceuticals Ltd gained for a third straight session today. The stock is quotin...

Read more

07 Feb 2025 13:05

News

Torrent Pharmaceuticals Ltd slips for fifth straight session

Torrent Pharmaceuticals Ltd is down for a fifth straight session today. The stock is quoti...

Read more

04 Feb 2025 13:35

News

Torrent Pharma gains after Q3 PAT rises 14% YoY to Rs 503 cr

Revenue from operations grew 2.6% year on year (YoY) to Rs 2,762 crore in the quarter ende...

Read more

27 Jan 2025 14:33

News

Board of Torrent Pharmaceuticals recommends interim dividend

Torrent Pharmaceuticals announced that the Board of Directors of the Company at its meetin...

Read more

24 Jan 2025 17:25

News

Torrent Pharmaceuticals to declare Quarterly Result

Torrent Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 24...

Read more

15 Jan 2025 10:12

SWOT Analysis Of Torrent Pharmaceuticals Ltd

Strength

4

S

Weakness

3

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Glenmark Pharmaceuticals Ltd

Strength

4

S

Weakness

2

W

Opportunity

1

O

Threats

1

T

BlinkX Score for Torrent Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Glenmark Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Glenmark Pharmaceuticals Ltd and Torrent Pharmaceuticals Ltd

Which company has a larger market capitalization, Glenmark Pharmaceuticals Ltd or Torrent Pharmaceuticals Ltd?

Market cap of Glenmark Pharmaceuticals Ltd is 39,374 Cr while Market cap of Torrent Pharmaceuticals Ltd is 106,184 Cr

What are the key factors driving the stock performance of Glenmark Pharmaceuticals Ltd and Torrent Pharmaceuticals Ltd?

The stock performance of Glenmark Pharmaceuticals Ltd and Torrent Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Glenmark Pharmaceuticals Ltd and Torrent Pharmaceuticals Ltd?

As of May 12, 2025, the Glenmark Pharmaceuticals Ltd stock price is INR ₹1395.25. On the other hand, Torrent Pharmaceuticals Ltd stock price is INR ₹3137.55.

How do dividend payouts of Glenmark Pharmaceuticals Ltd and Torrent Pharmaceuticals Ltd compare?

To compare the dividend payouts of Glenmark Pharmaceuticals Ltd and Torrent Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions